WeTrials
Recruiting

ICON-RT: Intracranial Consolidation and Deferral of Radiation Therapy in Patients Receiving Approved CNS-Active Systemic Therapeutics

What is this study?

This study is testing whether adding precise brain radiation to a targeted cancer pill works better than taking the pill alone for lung cancer that has spread to the brain. Researchers want to see if this combination helps control the disease while also protecting your overall quality of life.

Who can participate?

You may be able to join if you are 18 or older, have a specific type of lung cancer with an EGFR gene mutation, and have untreated brain tumors that are not currently causing urgent symptoms. You must either be new to targeted cancer pills or have started them within the last three months.

What will happen?

You will take a targeted cancer pill called osimertinib, and some participants will also receive a precise, high-dose brain radiation treatment called stereotactic radiosurgery after three months. Throughout the study, you will fill out questionnaires so the team can monitor how you are feeling.

Where and when?

This study is currently recruiting patients and takes place in locations including Miami, Florida, and Basking Ridge and Middletown, New Jersey.

Key Points
  • 1Tests the combination of a targeted cancer pill and precise brain radiation
  • 2Focuses on lung cancer that has spread to the brain
  • 3Measures both medical outcomes and your daily quality of life

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Non Small Cell Lung Cancer Metastatic

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.